Team Quantitates Phosphorylation Sites in Mice Sperm; May Lead to Male Contraceptive, Rxs | GenomeWeb

A team of investigators have used differential isotope labeling and mass spectrometry to identify 55 unique in vivo sites of phosphorylation and quantitated phosphorylation for 42 different phosphopeptides in murine sperm.

The work, which could provide a basis for the development of a male contraceptive and new drug therapies, "represents the first effort to determine which specific protein phosphorylation sites change their phosphorylation status in vivo as a result of the mammalian capacitation process," the researchers said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.